Dengue virus infection of mast cells triggers endothelial cell activation. 2011

Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia B3H 1X5, Canada.

Vascular perturbation is a hallmark of severe forms of dengue disease. We show here that antibody-enhanced dengue virus infection of primary human cord blood-derived mast cells (CBMCs) and the human mast cell-like line HMC-1 results in the release of factor(s) which activate human endothelial cells, as evidenced by increased expression of the adhesion molecules ICAM-1 and VCAM-1. Endothelial cell activation was prevented by pretreatment of mast cell-derived supernatants with a tumor necrosis factor (TNF)-specific blocking antibody, thus identifying TNF as the endothelial cell-activating factor. Our findings suggest that mast cells may represent an important source of TNF, promoting vascular endothelial perturbation following antibody-enhanced dengue virus infection.

UI MeSH Term Description Entries
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003716 Dengue Virus A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. Breakbone Fever Virus,Breakbone Fever Viruses,Dengue Viruses,Fever Virus, Breakbone,Fever Viruses, Breakbone,Virus, Breakbone Fever,Virus, Dengue,Viruses, Breakbone Fever,Viruses, Dengue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D018799 Intercellular Adhesion Molecule-1 A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Antigens, CD54,CD54 Antigens,ICAM-1,CD54 Antigen,Antigen, CD54,Intercellular Adhesion Molecule 1
D019010 Vascular Cell Adhesion Molecule-1 Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154) Antigens, CD106,CD106 Antigens,VCAM-1,CD106 Antigen,INCAM-110,Inducible Cell Adhesion Molecule 110,Vascular Cell Adhesion Molecule,Antigen, CD106,Vascular Cell Adhesion Molecule 1
D019138 Antibodies, Blocking Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989) Antibodies, Enhancing,Blocking Antibodies,Enhancing Antibodies

Related Publications

Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
December 2020, Viruses,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
April 2007, Thrombosis and haemostasis,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
January 2012, Advances in virology,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
June 1997, Journal of virology,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
January 2014, International journal of medical sciences,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
December 1998, Journal of immunology (Baltimore, Md. : 1950),
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
September 2015, Immunology,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
January 1995, Journal of clinical & laboratory immunology,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
June 2012, Journal of virology,
Michael G Brown, and Laura L Hermann, and Andrew C Issekutz, and Jean S Marshall, and Derek Rowter, and Ayham Al-Afif, and Robert Anderson
June 2017, DNA and cell biology,
Copied contents to your clipboard!